Uncategorized
Alcon’s Pazeo allergy drop available March 10
ATLANTA – Alcon’s new once daily Pazeo will be commercially available March 10, announced a company representative during a press conference here at SECO.Mike Burns, U.S. allergy brand manager for Alcon, said that Pazeo (olopatadine HCl ophthalmic solution 0.7%), which the FDA approved Jan. 30, will be available to doctors next week.